In Rare Instances, South Africa Variant May Evade Pfizer Vaccine, Researchers Say

2021-04-13 | , ABC

April 12, 2021 - The first real-world study pitting COVID-19 variants against the Pfizer vaccine showed that the variant first detected in South Africa may be able to evade some vaccine protection, new research conducted in Israel found. While "breakthrough" COVID-19 cases, meaning people who get infected or sick despite being vaccinated, are extremely rare, health experts have been monitoring a handful of virus variants to see if current vaccines offer robust protection against them. Read the full article here

2016 American Dental Education Association (ADEA), 655 K Street, NW, Suite 800, Washington, DC 20001 (202) 289-7201